Publications

11.30.08MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts read more
11.16.08Potent inhibition of microRNA in vivo without degradation read more

News

01.25.10Regulus, Alnylam and Isis Announce U.S. Allowance of Tuschl III Patent Application Covering miR-21 read more
01.15.10Regulus Therapeutics Present New Pre-clinical Data from Multiple Therapeutic Programs at Keystone Symposium read more